Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

NCT00954941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Diseases
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Chronic Myelogenous Leukemia

Interventions

DRUG: Ondansetron
DRUG: Aprepitant

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]